Kiyotaka Takefuta

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

A novel de novo calmodulin mutation in a 6-year-old boy who experienced an aborted cardiac arrest

Kazuhiro Takahashi, Taisuke Ishikawa, Naomasa Makita et al. · HeartRhythm Case Reports · 2016 · 23 citations · Full text

Medicine, Cardiology, Pediatrics +17

Growing potential of small aortic valve with aortic coarctation or interrupted aortic arch after bilateral pulmonary artery banding

Tai Fuchigami, Masahiko Nishioka, Toru Akashige et al. · Interactive Cardiovascular and Thoracic Surgery · 2016 · 13 citations · Full text

Medicine, Cardiology, Surgery +16